Impact of iodine supplementation of dairy cows on milk production and iodine concentrations in milk

AIM: To determine the effect of iodine supplementation on milk production and iodine concentrations in milk for pasture-fed, seasonally calving dairy cows. METHODS: The study was run over two consecutive seasons on the same dairy farm. In Trial One, 294 Friesian dairy cows were either untreated or injected intramuscularly three times with iodised oil (2,370 mg iodine/dose) at the start of lactation (Day 1) and at about 100-day intervals thereafter. Iodine concentrations in milk were determined prior to each injection on Days 1, 98 and 210, and milk, fat and protein yields measured on Days 43, 98, 176 and 238. In Trial Two, 234 Friesian dairy cows were either untreated or injected intramuscularly with iodised oil (2,370 mg iodine/dose) in early lactation (Day 1) and 99 days later. Iodine concentrations in milk were determined prior to treatment on Days 1, 55 and 161. Serum thyroxine (T4) and triiodothyronine (T3) concentrations were determined in the latter two samples and milk, protein and fat yields were determined on Days 25, 119, 182 and 221. In both trials, pasture was sampled at 1- or 3-monthly intervals and iodine concentrations in herbage measured. RESULTS: Iodine concentrations in pasture averaged 0.24 mg/kg dry matter (DM) in both seasons and varied little over the experimental period. Iodine concentrations in milk from unsupplemented cows were <20 microg/L in both trials. Three iodine injections at about 100-day intervals increased iodine concentrations in milk to 58 microg/L for at least 98 days after each treatment. Two iodine injections at about 100-day intervals raised milk iodine concentrations to 160 microg/L and 211 microg/L at least 55 days after each treatment, but had no effect on serum thyroid hormone concentrations. Iodine supplementation had no significant effect on milk, milkfat or milk protein yield. CONCLUSIONS: Pastures in New Zealand that contained 0.24 mg iodine/kg DM appeared to provide an adequate iodine intake for dairy cows. Intramuscular injections of iodine resulted in significant increases in iodine concentrations in milk. CLINICAL SIGNIFICANCE: Increasing iodine concentrations in milk via intramuscular injection of iodine could provide a method for significantly increasing iodine intakes of humans, in particular, children.     

The dynamic influence of the DRB1*1101 allele on the resistance of sheep to experimental Teladorsagia circumcincta infection

ABSTRACT: Suffolk sheep carrying the DRB1*1101 (previously referred to as-DRB1*0203 or G2) allele have been reported to show increased resistance to natural Teladorsagia circumcincta infection compared to non-carriers. The objective of this study was to compare the biochemical and physiological responses of DRB1*1101 carrier and non-carrier twin lambs to an experimental infection with 3 × 104 L3 Teladorsagia circumcincta. The variables studied included worm burden, faecal egg count, abomasal mast cells, IgA, IgE, IgG1 plus IgG2 and haematological parameters at 0, 3, 7, 21 and 35 days post infection (dpi), and duodenal smooth muscle contractility at 0 and 35 dpi. DRB1*1101 carrier lambs had significantly lower worm burden, higher mast cell and plasma platelet counts than the DRB1*1101 non-carriers (P < 0.05). Before infection, the non-carrier lambs exhibited significantly higher mucosal levels of all antibody isotypes measured compared to the carriers; these levels remained relatively stable over the course of infection in the non-carriers while there was a slow build up of these antibodies in the carriers up to day 21 post infection (pi). The DRB1*1101 non-carrier lambs had a significantly higher plasma lymphocyte count, and produced greater duodenal contractile force relative to the carrier lambs (P < 0.05). There was no significant difference between genotypes in the level of plasma eosinophils, monocytes, neutrophils or FEC. This evidence suggests that resistance conferred by DRB1*1101 is acquired rather than innate, depends on worm expulsion rather than fecundity and is dependent on mucosal mast cell proliferation, platelet activation, and IgA and IgE antibody responses.     

Isolation and detection of Fasciola hepatica DNA in Lymnaea viatrix from formalin-fixed and paraffin-embedded tissues through multiplex-PCR

Detection of Fasciola hepatica infection in Lymnaea viatrix through analysis of histological cuts is based upon morphological characters of the parasite during the intra-mollusk phase of parasitism. At this stage, trematode forms are very similar and, thus, very difficult to differentiate. Specific detection may also be impaired by the presence of other helminthes in the mollusk. Histological samples are usually fixed in formalin, embedded in paraffin, sectioned and HE stained. In the current study, a method for the extraction of DNA from formalin-fixed, paraffin-embedded tissues was standardized by means of deparaffinizing with xylol and digesting with proteinase K. Extracted DNA was amplified in a multiplex-PCR, by using simultaneous primers in a single reaction under high stringency conditions. Results showed specific amplification of DNA from the trematode and the snails. The technique was sensitive enough to detect F. hepatica infections in L. viatrix, in histological sections in which the presence of larval stages could not be observed through brightfield microscopy. The profiles generated were: stair bands referring to F. hepatica DNAmt amplification; a band of 1200 bp referring to L. viatrix ITS and another of 1300 bp referring to F. hepatica ITS and other trematodes. Multiplex-PCR has shown to be a fast, safe, highly sensitive and specific method, which is able to amplify DNA from fixed tissues, despite a low DNA quantity and its degradation caused by fixation processes. Such methodology may be useful in studies on fascioliasis epidemiology, enabling the use of material from histological collections.     

A practical approach to managing the risks of iodine deficiency in flocks using thyroid-weight:birthweight ratios of lambs

AIM: To establish a protocol for determining the iodine status of a flock and managing the risks of iodine deficiency, using thyroid-weight:birthweight ratios of newborn lambs and serum iodine concentrations of ewes.

METHODS: Data were collected from iodine supplementation studies in Southland and Rangitikei, of sheep fed exclusively pasture or pasture plus brassica during the latter half of gestation (n=350, or 89 per treatment group). The ewes were supplemented pre-mating or at the time of pregnancy scanning with an injection of long-acting iodised oil. Serum iodine concentrations were measured in ewes prepartum in Rangitikei and postpartum at both locations. The thyroid-weight:birthweight ratios (as g/kg) in 229 newborn lambs were determined at post-mortem examination and compared between iodine supplemented vs unsupplemented flocks using probit analysis. Samples of pasture and kale were analysed monthly for determination of iodine and selenium.

RESULTS: Initial mean serum iodine concentration of all ewes was 41 µg iodine/L. Supplementation increased serum iodine concentrations regardless of forage fed, and concentrations remained high for between 127 and 206 days. The range of thyroid-weight:birthweight ratios in lambs from supplemented ewes was 0.09–0.70 (mean 0.35, standard deviation (SD) 0.147) g/kg. Among lambs from unsupplemented ewes, the range was much wider (0.21–8.5; mean 1.61, SD 1.95 g/kg). About half of those ratios were >0.8 g/kg and clearly indicative of goitre, including 62% from the groups on brassica and 18% from the Rangitikei group fed exclusively pasture. Probit calculations showed that a ratio of 0.40 (95% confidence interval (CI)=0.29–0.47) g/kg predicted with 35% probability, and a ratio of 0.80 (95% CI=0.70–0.99) g/kg predicted with 90% probability that a lamb came from an unsupplemented flock.

CONCLUSIONS: Compared to iodine concentrations in forages, thyroid-weight:birthweight ratios more accurately reflected the iodine status of the flock and could be used to identify which flocks to supplement the following year. Serum iodine concentrations of ewes measured before or after lambing did not reflect forage fed, but values near 40 µg/L were associated with goitrous lambs.

CLINICAL RELEVANCE: Thyroid-weight:birthweight ratios >0.8 g/kg were indicative of iodine deficiency, and ewes should be supplemented pre-mating or during pregnancy to prevent goitre the following year. Ratios <0.4 g/kg rarely occurred among deficient flocks, so the probability of benefit from supplementation was low. Intermediate ratios were ambiguous, and the iodine status of the flock could not be determined from biomarkers. In such cases individual-farm supplementation trials might be required to detect and manage the risks of marginal deficiency.     

Growth response to increasing doses of microencapsulated vitamin B12 and related changes in tissue vitamin B12 concentrations in cobalt-de cient lambs

AIM: To investigate growth responses of cobalt-deficient lambs to increasing doses of microencapsulated vitamin B₁₂, and to measure associated changes in serum and liver vitamin B₁₂ concentrations over 243 days.

METHODS: From a flock grazing pastures that had low cobalt (Co) levels (about 0.06 mg Co/kg dry matter), 4-6-week-old lambs (n=137) were assigned to four groups and received either no treatment or a subcutaneous injection of 3.0, 4.5 or 6.0 mg of microencapsulated vitamin B₁₂ on Day 1. At approximately monthly intervals, all lambs were weighed and blood samples were collected from a selection (n=10) of monitor animals, up to Day 243. Liver biopsies were also carried out on the monitor lambs (n=8) on Days 1, 124 and 215.

RESULTS: The vitamin B₁₂-treated lambs grew significantly faster (p<0.001) than untreated animals. Liveweights after 243 days were 28, 45, 45 and 47 kg for the untreated, 3.0, 4.5 and 6.0 mg vitamin B₁₂-treated lambs, respectively. Of the initial group of untreated lambs, 68% had to be removed before the end of the trial because of substantial weight loss, but none of the treated animals were similarly afflicted. Serum vitamin B₁₂ concentrations increased in all vitamin B₁₂-treated lambs, reaching a peak at Day 25, and those of the 4.5 and 6.0 mg vitamin B₁₂-treated lambs remained significantly higher (except at Day 124) than the untreated lambs to Day 187. However, at Day 124, but not Day 215, the liver vitamin B₁₂ concentrations of treated lambs were two to three times higher than those of controls.

CONCLUSIONS: The growth rates of Co-deficient lambs were markedly improved by injection of 3.0, 4.5 or 6.0 mg of microencapsulated vitamin B₁₂, and liveweights were maintained for at least 243 days. Serum vitamin B₁₂ concentrations were related to this growth response; concentrations of <220 pmol vitamin B₁₂/l were associated with a 95% probability that lambs were Co-deficient and would thus respond to Co/vitamin B₁₂ supplementation. Based on these data, the current New Zealand reference criteria for Co deficiency should be reviewed.

CLINICAL SIGNIFICANCE: An injection of 3 mg microencapsulated vitamin B₁₂2 given to lambs at tailing will treat Co deficiency and will increase and maintain liveweights in a flock for up to 8 months.     

An evaluation of the efficacy of injectable microencapsulated vitamin B12 in increasing and maintaining the serum and liver vitamin B12 concentrations of lambs

AIM: To develop a long-acting Vitamin B12 injection to prevent Co deficiency in sheep. METHODS: Formulations of microencapsulated Vitamin B12 in lactide-glycolide polymers were injected intramuscularly or subcutaneously into the anterior neck region of groups of 10 lambs and their efficacy determined from changes in serum and liver Vitamin B12 concentrations. RESULTS: The 95:5 lactide glycolide and the 100 lactide formulations containing more than 12.5% Vitamin B12 w/w significantly increased and maintained serum Vitamin B12 concentrations for at least 210 days as well as liver Vitamin B12 concentrations in treated lambs when compared with untreated controls. CONCLUSIONS: Injections of microencapsulated Vitamin B12 in lactide/glycolide copolymers are able to increase and maintain the Vitamin B12 status of lambs for at least 210 days. CLINICAL SIGNIFICANCE: Another option for the prevention of Co deficiency in sheep is now available using a long acting injectable Vitamin B12.